Advertisement
Home Authors Posts by HealthDay.com

HealthDay.com

HealthDay.com
38619 POSTS 0 COMMENTS
A blood test that can quickly diagnose dangerous sepsis infections has been developed

Experimental Test May Quickly Diagnose Sepsis

0
Microelectrode device analyzes a patient's blood, provides results in as quickly as 2.5 minutes
Plazomicin is noninferior to meropenem for patients with complicated urinary tract infections

Plazomicin Noninferior to Meropenem for Complicated UTI

0
In second study, plazomicin may be beneficial for carbapenem-resistant Enterobacteriaceae infections
In sedentary overweight/obese older adults

Morning Exercise Linked to BP Reduction in Sedentary Seniors

0
Additional reduction seen in average systolic BP with combination of morning exercise and regular breaks
A deep learning-enhanced device can accurately detect diabetic retinopathy

Deep Learning-Enhanced Device Detects Diabetic Retinopathy

0
Device sensitivity/specificity 100/97.8 percent for vision-threatening diabetic retinopathy
The microbiome of patients with systemic lupus erythematosus

Altered Gut Microbiome Seen in Patients With Active Lupus

0
Patients with lupus had fivefold greater representation of Ruminococcus gnavus
For first-line therapy of metastatic renal cell carcinoma

Combo Regimens Effective for Tx of Metastatic Renal Cell Cancer

0
Two large trials show benefits for pembrolizumab-axitinib and avelumab-axitinib versus sunitinib
Between 1997 and 2014

1997 to 2014 Saw Large Hike in Screen Time for Ages 0 to 2

0
Television accounted for most screen time in children aged 0 to 2 and 3 to 5 years in 2014
Higher consumption of nuts

Eating Nuts Tied to Reduced CVD Incidence, Death in T2DM Patients

0
Reduced risk seen for total CVD, coronary heart disease incidence for men and women
Cancer death rates are decreasing faster in blacks than whites in the United States

Black-White Cancer Mortality Gap Decreasing in Some Age Groups

0
Cancer deaths rates decreasing faster for black men and women vs. white men and women in U.S.
Long-term outcomes are more favorable for early intensive treatment versus first-line moderate-efficacy disease-modifying therapy in multiple sclerosis

Early Intensive Treatment May Improve Long-Term MS Outcomes

0
Mean five-year change lower in Expanded Disability Status Scale score with early intensive treatment